Dr. Cecilia Pang, Biotechnology Director of the Hong Kong SAR Government’s Innovation and Technology Commission (ITC), discusses ITC’s mandate to develop the necessary infrastructure in order to foster Hong Kong’s innovation and technology environment, the increasing importance and relevance of the life sciences sector to Hong Kong, and the strengths of Hong Kong in terms of becoming a life sciences innovation hub.
To begin with, can you briefly comment on the overall mandate of the Innovation and Technology Commission (ITC)?
"We were a latecomer to the industry because we do not have a large pharma industry base, but we are very strong in academic research, especially in biomedical and clinical research."
